We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Teva Pharmaceuticals had record net sales of $2.82 billion in the second quarter, up 18 percent from the same period last year, the firm said in a conference call.